| Literature DB >> 31057523 |
Chao-Jung Wu1, Hsu-Feng Lu2,3, Yi-Tsung Lin4,5, Man-San Zhang1, Li-Hua Li6,7, Tsuey-Ching Yang1.
Abstract
Stenotrophomonas maltophilia is an emerging multi-drug resistant opportunistic pathogen. Although fluoroquinolones (FQ) are still clinically valuable for the treatment of S. maltophilia infection, an increasing prevalence in FQ resistance has been reported. Overexpression of SmeDEF, SmeVWX, and SmQnr, and de-repressed expression of heat shock response are reported mechanisms responsible for FQ resistance in S. maltophilia; nevertheless, some of these mechanisms are identified from laboratory-constructed mutants, and it remains unclear whether they occur in clinical setting. In this study, we aimed to assess whether these mechanisms contribute substantially to FQ resistance in clinical isolates. Eighteen ciprofloxacin- and levofloxacin-resistant isolates were selected from 125 clinical isolates of S. maltophilia. The expression of smeE, smeW, and Smqnr genes of these isolates was investigated by RT-qPCR. The de-repressed heat shock response was assessed by rpoE expression at 37°C and bacterial viability at 40°C. The contribution of SmeDEF, SmeVWX, and SmQnr, and heat shock response to FQ resistance was evaluated by mutants construction and susceptibility testing. The results demonstrated that simply assessing the overexpression of SmeDEF, SmeVWX, and SmQnr by RT-qPCR may overestimate their contribution to FQ resistance. Simultaneous overexpression of SmeDEF and SmeVWX did not increase the resistance level to their common substrates, but extended the resistance spectrum. Moreover, the de-repressed expression of heat shock response was not observed to contribute to FQ resistance in the clinical isolates of S. maltophilia.Entities:
Keywords: Qnr protein; Stenotrophomonas maltophilia; efflux pump; fluoroquinolone resistance; heat shock response
Year: 2019 PMID: 31057523 PMCID: PMC6479208 DOI: 10.3389/fmicb.2019.00822
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Antibiotic susceptibility and the expressions of smeE, smeW, smqnr, and rpoE genes of S. maltophilia isolates.
| MICa (μg/ml) | RT-qPCRb (fold) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| FQ | CHL | TET | Macrolide | |||||||
| Isolate | CIP | LEV | ERV | LM | ||||||
| KJ | 1 | 1 | 8 | 16 | 64 | 256 | 1 | 1 | 1 | 1/5.9 ± 1.9c |
| KJΔRseA | 1 | 1 | 8 | 16 | 64 | 256 | 0.9 ± 0.1 | 1.3 ± 0.2 | 1.5 ± 0.1 | 4.5 ± 2.3 |
| KJΔRpoEΔRseA | 1 | 1 | 8 | 16 | 64 | 256 | 1.3 ± 0.3 | 0.8 ± 0.1 | 0.7 ± 0.2 | – – |
| V47 | 16 | 16 | 128 | 16 | 128 | 1024 | 4.9 ± 0.1 | 6.5 ± 1.0 | 5.7 ± 0.0 | 5.5 ± 1.3 |
| V53 | 8 | 16 | 32 | 16 | 512 | 4096 | 69.0 ± 4.0 | 0.5 ± 0.4 | 2.6 ± 0.4 | 2.4 ± 0.5 |
| V56 | 16 | 8 | 64 | 128 | 512 | 2048 | 0.7 ± 0.0 | 18.4 ± 1.4 | 1.9 ± 0.1 | 14 ± 9.5 |
| V61 | 8 | 8 | 32 | 64 | 512 | 4096 | 48.4 ± 2.7 | 0.9 ± 0.0 | 15.7 ± 4.5 | 5.7 ± 0.4 |
| V62 | 8 | 8 | 8 | 128 | 128 | 4096 | 0.7 ± 0.0 | 0.3 ± 0.0 | 0.8 ± 0.0 | 10.5 ± 1.5 |
| V63 | 8 | 8 | 32 | 64 | 512 | 4096 | 67.4 ± 14.1 | 0.6 ± 0.0 | 2.1 ± 0.1 | 2.7 ± 0.2 |
| V78 | 32 | 32 | 64 | 256 | 256 | 2048 | 54.6 ± 8.4 | 0.6 ± 0.1 | 58.9 ± 6.8 | 8.5 ± 1.7 |
| V80 | 8 | 16 | 32 | 64 | 256 | 4096 | 0.6 ± 0.0 | 0.5 ± 0.2 | 0.7 ± 0.0 | 3.9 ± 0.7 |
| V82 | 4 | 8 | 128 | 16 | 256 | 2048 | 21.4 ± 0.8 | 0.6 ± 0.0 | 1.3 ± 0.1 | 0.4 ± 0.1 |
| V84 | 16 | 16 | 32 | 64 | 512 | 4096 | 99.7 ± 18.6 | 0.2 ± 0.0 | 1.8 ± 0.0 | 12.9 ± 2.0 |
| V90 | 8 | 16 | 16 | 32 | 512 | 4096 | 73.7 ± 6.4 | 38.0 ± 0.5 | 4.9 ± 3.1 | 2.1 ± 1.6 |
| V93 | 16 | 32 | 32 | 64 | 512 | 4096 | 92.3 ± 4.1 | 0.6 ± 0.0 | 2.3 ± 0.1 | 0.5 ± 0.1 |
| V95 | 8 | 16 | 64 | 16 | 256 | 2048 | 3.2 ± 0.0 | 4.4 ± 1.6 | 0.3 ± 0.1 | 1.5 ± 0.5 |
| V96 | 32 | 32 | 64 | 256 | 256 | 1024 | 6.1 ± 0.4 | 0.6 ± 0.2 | 4.9 ± 0.6 | 2.8 ± 0.2 |
| V99 | 8 | 16 | 128 | 8 | 256 | 1024 | 0.5 ± 0.0 | 8.6 ± 0.8 | 0.4 ± 0.0 | 5.4 ± 0.9 |
| V101 | 4 | 8 | 64 | 16 | 128 | 1024 | 4.3 ± 1.6 | 0.5 ± 0.1 | 20.2 ± 2.1 | 2.9 ± 1.4 |
| V104 | 8 | 16 | 32 | 64 | 256 | 4096 | 59.3 ± 3.3 | 7.8 ± 1.6 | 4.9 ± 0.0 | 2.1 ± 1.1 |
| V105 | 8 | 16 | 32 | 64 | 256 | 4096 | 0.4 ± 0.0 | 0.7 ± 0.0 | 0.5 ± 0.0 | 3.3 ± 0.3 |
Antibiotic susceptibilities of clinical isolates and their derived mutants.
| Strain | MICa (μg/ml) | |||||
|---|---|---|---|---|---|---|
| FQ | Macrolide | |||||
| CIP | LEV | CHL | TET | ERY | LM | |
| KJ | 1 | 1 | 8 | 16 | 64 | 256 |
| KJΔDEF | 0.5 | 0.5 | 4 | 8 | 32 | 128 |
| KJΔ5 | 1 | 1 | 8 | 16 | 64 | 256 |
| KJΔQnr | 1 | 1 | 8 | 32 | 64 | 256 |
| KJΔRseA | 1 | 1 | 8 | 16 | 64 | 256 |
| KJΔRpoE | 1 | 1 | 8 | 16 | 64 | 256 |
| KJΔRpoEΔRseA | 1 | 1 | 8 | 16 | 64 | 256 |
| V53 | 8 | 16 | 32 | 16 | 512 | 4096 |
| V53ΔDEF | 8 | 16 | 32 | 16 | 512 | 4096 |
| V63 | 8 | 8 | 32 | 64 | 512 | 4096 |
| V63ΔDEF | 0.5 | 0.125 | 4 | 4 | 16 | 64 |
| V82 | 4 | 8 | 128 | 16 | 256 | 2048 |
| V82ΔDEF | 4 | 8 | 128 | 16 | 256 | 2048 |
| V99 | 8 | 16 | 128 | 8 | 256 | 1024 |
| V99Δ5 | 0.5 | 1 | 16 | 8 | 256 | 1024 |
| V47 | 16 | 16 | 128 | 16 | 128 | 1024 |
| V47ΔDEF | 16 | 16 | 128 | 8 | 32 | 256 |
| V47Δ5 | 0.25 | 0.5 | 8 | 16 | 128 | 1024 |
| V47ΔDEFΔ5 | 0.25 | 0.5 | 8 | 8 | 32 | 128 |
| V47ΔSmqnr | 4 | 4 | 128 | 16 | 128 | 512 |
| V47ΔSmqnr(pSmqnrC) | 8 | 8 | 128 | 16 | 128 | 512 |
| V47ΔRpoE | 16 | 16 | 128 | 16 | 128 | 1024 |
| V61 | 8 | 8 | 32 | 64 | 512 | 4096 |
| V61ΔRpoE | 8 | 8 | 32 | 64 | 512 | 4096 |
| V84 | 16 | 16 | 32 | 64 | 512 | 4096 |
| V84ΔRpoE | 16 | 16 | 32 | 64 | 512 | 4096 |
FIGURE 1Viability of S. maltophilia isolates and their derived mutants after heat shock. The logarithmic-phase bacterial cells were collected, adjusted to 2 × 105 CFUs/μl, and 10-fold serially diluted. Then 5 μl of the bacterial cells were spotted on LB agar. After an 18-h incubation period, bacterial cell growth was observed. (A) Incubation at 37°C. (B) Incubation at 40°C.